📰 Summits Transl Sci News

Summits Transl Sci News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Summits Transl Sci. Real-time updates on events, politics, business and more.

Janssen's Save Legs. Change Lives.™ is Creating a More Equitable Future for Communities at Risk of PAD-Related Amputations

November 4, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first impact summary for its Save Legs. Change Lives.™ Spot...

United States Pamela Parker Richard Browne Pernessa Seele Cardiovascular Health Equity Advisory Council Community Health Advocate Training

Source: prnewswire.com

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease

May 31, 2022

COMPASS open label extension study results support the long-term use of XARELTO plus aspirin for vascular protection in patients with chronic CAD and/or PAD

United States John Eikelboom Keith Fox American Heart Association International Society On Thrombosis Janssen Research Development

Source: dicardiology.com

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions

April 1, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial...

United States Mark Svet None Of The Janssen Pharmaceutical Companies American Heart Association American College Of Cardiology Janssen Pharmaceuticals Inc

Source: prnewswire.com

Clinical Architecture Announces the Release of SeekDx™ for Clinical and Billing Documentation

March 14, 2022

/PRNewswire/ -- Clinical Architecture, a leading provider of healthcare interoperability and data quality solutions, is excited to announce the release of...

United States American Medical Association Harvard School Of Public Health Defense Health Agency Harvard School Public Health

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Summits Transl Sci News Today

Janssen's Save Legs. Change Lives.&#x2122; is Creating a More Equitable Future for Communities at Risk of PAD-Related Amputations

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO&#xA0;Plus Aspirin in Patients with Coronary Artery Disease,&#xA0;Peripheral Artery Disease

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO&#xAE; (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions

Clinical Architecture Announces the Release of SeekDx&#x2122; for Clinical and Billing Documentation

Explore More Categories

Janssen's Save Legs. Change Lives.™ is Creating a More Equitable Future for Communities at Risk of PAD-Related Amputations

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions

Clinical Architecture Announces the Release of SeekDx™ for Clinical and Billing Documentation